Absci Corporation - stock earnings
ABSI Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -22.0 million USD | 744000 USD |
| 2023Q2 | -41.7 million USD | 3.4 million USD |
| 2023Q1 | -23.4 million USD | 1.3 million USD |
| 2022Q4 | -19.5 million USD | 1.6 million USD |
| 2022Q3 | -27.3 million USD | 2.4 million USD |
| 2022Q2 | -28.7 million USD | 1.0 million USD |
| 2022Q1 | -29.5 million USD | 819000 USD |
| 2021Q4 | -25.2 million USD | 1.5 million USD |
| 2021Q3 | -23.6 million USD | 1.5 million USD |
| 2021Q2 | -41.2 million USD | 728000 USD |
| 2021Q1 | -11.0 million USD | 1.1 million USD |
| 2020Q4 | -4.9 million USD | 2.7 million USD |
| 2020Q3 | -3.7 million USD | 916000 USD |
| 2020Q2 | -3.0 million USD | 564000 USD |
| 2020Q1 | -2.7 million USD | 572000 USD |
ABSI Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -106.5 million USD | 6.9 million USD |
| 2022 | -104.9 million USD | 5.7 million USD |
| 2021 | -101.0 million USD | 4.8 million USD |
| 2020 | -14.6 million USD | 4.8 million USD |
| 2019 | -6.8 million USD | 2.1 million USD |
ABSI
Price: $5.08
52 week price:
Earnings Per Share: -1.20 USD
P/E Ratio: -3.71
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 382100
Market Capitalization: 579.7 million